These terms govern use of the public NeuroRisk.ai website and public intelligence surfaces. Contracted enterprise services may be governed by a separate agreement, order form, data-processing agreement or statement of work; where those terms conflict with these public terms, the signed enterprise agreement controls for the contracted service.
NeuroRisk.ai provides neuroscience research, clinical-trial, company, market, regulatory and evidence intelligence for research strategy and enterprise decision support. Public scores, rankings and reports are analytical signals derived from indexed evidence and disclosed transformations.
Content does not constitute medical diagnosis or treatment, regulatory or legal advice, patent clearance or freedom-to-operate analysis, actuarial advice, investment advice, or a guarantee of clinical, regulatory, commercial or financial outcome. Appropriate qualified review remains necessary for consequential decisions.
NeuroRisk uses public and licensed metadata sources and internal normalization, scoring and graph transformations. Source coverage, update timing and completeness vary. Indexed counts are not represented as exhaustive global totals unless expressly stated. Source identifiers, methodology and limitations are published where available.
You may use public content for legitimate evaluation, research and business purposes. You may not attempt unauthorized access, bypass security controls, interfere with service availability, introduce malicious code, misrepresent NeuroRisk outputs, or use automated access in a manner that materially degrades the service or violates applicable source terms.
Third-party source records remain subject to their respective rights and terms. NeuroRisk retains rights in its original software, interface, taxonomies, transformations, scoring logic, report structure, compilations and branding to the extent permitted by law and applicable agreements.
Authenticated features, APIs, exports, quotas, service levels, confidentiality, permitted users and commercial rights may be subject to separate enterprise terms. Users are responsible for protecting credentials assigned to them and for activity under their authorized access.
Public features, datasets and analytical methods may evolve as sources, evidence and product capabilities change. Material report methodology is versioned. NeuroRisk may modify, suspend or retire public surfaces when necessary for security, quality, source compliance or product maintenance.
Links to ClinicalTrials.gov, PubMed, DOI resolvers, OpenAlex, World Bank, FDA and other external services are provided for provenance and convenience. Availability and content of those services are controlled by their operators, not NeuroRisk.ai.
For legal, procurement, security or enterprise-contract questions, use the NeuroRisk contact channel. Applicable contractual rights, warranties, liability allocations, governing law and data-processing terms should be established in the executed enterprise agreement where required.
Contact NeuroRisk →